Massachusetts General researchers identify new target for cancer immunotherapy – EurekAlert (press release)
|
Massachusetts General researchers identify new target for cancer immunotherapy
EurekAlert (press release) Massachusetts General Hospital investigators have found new evidence that the tumor necrosis factor receptor type II (TNFR2) may be a major target for immuno-oncology treatments, which induce a patient's immune system to fight cancer. TNFR2 is … |
